CancerSEEK is a blood test (also called a liquid biopsy) designed to detect multiple types of cancer at the earliest stages possible, before noticeable symptoms occur.
CancerSEEK is being developed to combine cutting-edge liquid biopsy technology with a machine learning engine, which will enable the test to improve with every person that is screened. It is designed to be integrated into your routine medical care, alongside other existing cancer screening tools.
With the CancerSEEK test as our foundation, we are developing and building not just the test itself, but a comprehensive and integrated service that includes result interpretation, follow-up testing, confirmed cancer diagnosis and facilitation into oncology care. At Thrive Earlier Detection, we will be a partner for healthy patients, cancer patients and physicians throughout the entire journey.
CancerSEEK is currently in development and is not yet available to patients. Information about enrolling in upcoming clinical trials will be provided in the future.
Back To What We Do